Cover Image

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Saved in:

Bibliographic Details
Main Authors:	Yusi Chen (Author), Jun Luo (Author), Jingyuan Chen (Author), Eugene Kotlyar (Author), Zilu Li (Author), Wenjie Chen (Author), Jiang Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study
by: Yusi Chen, et al.
Published: (2022)

Ambrisentan for the treatment of pulmonary arterial hypertension
by: Brian Casserly, et al.
Published: (2008)

Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension
by: Monaco TJ, et al.
Published: (2016)

Real-World Safety and Clinical Outcomes of Macitentan in Asian Patients with Pulmonary Arterial Hypertension: A Prospective Multicenter Study
by: Su Young Jung, et al.
Published: (2022)

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)
by: Jun Luo, et al.
Published: (2023)

A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients
by: Dunbar Ivy, MD, et al.
Published: (2020)

Extractive Spectrophotometric Determination of Ambrisentan
by: Chandra Bala Sekaran, et al.
Published: (2013)

Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension
by: Xinmei Li, et al.
Published: (2020)

The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan
by: Thomas L. Williams, et al.
Published: (2024)

Bladder Endothelin-1 Receptor Binding of Bosentan and Ambrisentan
by: Ayaka Osano, et al.
Published: (2014)

The endothelin receptor antagonist macitentan for the treatment of pulmonary arterial hypertension: A cross‐species comparison of its cytochrome P450 induction pattern
by: Alexander Treiber, et al.
Published: (2020)

Benefits of Macitentan in Patients with Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Jinlv Qin, et al.
Published: (2023)

Effects of bergapten on the pharmacokinetics of macitentan in rats both in vitro and in vivo
by: Jia Xu, et al.
Published: (2023)

Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS
by: Tian Lan, et al.
Published: (2021)

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH
by: Miren Bravo, et al.
Published: (2021)

Relative bioavailability of a pediatric dispersible tablet and adult film‐coated tablet of macitentan in healthy volunteers
by: Patricia N. Sidharta, et al.
Published: (2020)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
by: Jenna M. Faircloth, et al.
Published: (2023)

Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic
by: Dénes Csonka, et al.
Published: (2021)

TaqMan Probe-Based Quantitative Real-Time PCR to Detect Panax notoginseng in Traditional Chinese Patent Medicines
by: Qian Lou, et al.
Published: (2022)

Leflunomide-induced pulmonary arterial hypertension in a young man with nephrotic syndrome: A case report
by: Xiaoqin Luo, et al.
Published: (2022)

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
by: Yu-Yang Liu, et al.
Published: (2023)

Real-word adrenocorticotropic hormone treatment for childhood-onset nephrotic syndrome
by: Ying Wang, et al.
Published: (2023)

Assessing personalized molecular portraits underlying endothelial-to-mesenchymal transition within pulmonary arterial hypertension
by: Ruhao Wu, et al.
Published: (2024)

Corrigendum: The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook
by: Mingyao Luo, et al.
Published: (2022)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
by: Yong-Jie Chen, et al.
Published: (2021)

Discharge planning for children with ventricular septal defect and pulmonary arterial hypertension in China
by: Xiaoxiao Wu, et al.
Published: (2015)

Bioequivalence and the food effect of macitentan/tadalafil 10/20 fixed‐dose combination tablets versus the use of single‐component tablets in healthy subjects
by: Jennifer Lynn Ford, et al.
Published: (2024)

The Last Words (Real and Traditional) of Distinguished Men and Women
by: Marvin, Frederic Rowland, 1847-1918

Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway [Corrigendum]
by: Zhou X, et al.
Published: (2017)

Navigating a Difficult Transition in Pulmonary Arterial Hypertension: A Clinical Case Study
by: Tina Hyman, et al.
Published: (2019)

Corrigendum: Echocardiographic Evaluation of Transitional Circulation for the Neonatologists
by: Yogen Singh, et al.
Published: (2020)

Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension
by: Yanjiang Xing, et al.
Published: (2024)

Supplementation with Tex261 provides a possible preventive treatment for hypoxic pulmonary artery hypertension
by: Shaokun Chen, et al.
Published: (2022)

Anomalous Origin of the Right Coronary Artery from the Pulmonary Artery in an Infant
by: Shan-Miao Lin, et al.
Published: (2016)

Naringin Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension Through Endothelial-To-Mesenchymal Transition Inhibition
by: Yonghui Wu, et al.
Published: (2021)

Corrigendum to "Ultra-low dose combined spinal-epidural anesthesia for cesarean section in ritodrine-related severe pulmonary hypertension" [Taiwan J Obstet Gynecol, 52 (2013) 617]
by: Shin-Yan Chen, et al.
Published: (2014)

Optimizing care transitions: the role of the community pharmacist [Corrigendum]
by: Melody KT, et al.
Published: (2019)

Corrigendum: Advances in the study of acetaminophen-induced liver injury
by: Xinghui Li, et al.
Published: (2023)

Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension
by: Zhijie Yu, et al.
Published: (2022)

The Role of Second Language Reading Proficiency in Moderating Second Language Word Recognition
by: Xiaomeng Li, et al.
Published: (2024)